JOHNSON & JOHNSON Long-Term Concentrated

Location: New Brunswick, NJ

CIK: 0000200406 · Show all filings

Period: Q4 2025 (← Previous) (Next →)

Filing Date: Mar 18, 2026

Total Value: $555M (100.0% shares, 0.0% debt)

Holdings (17)

PTGX Protagonist Therapeutics Inc. 38.5%

Value $214M Shares 2,449,183 Share Price $87.34 Est. Cost/Share $42.63 Unrealized @ Report Date +104.9%

NBTX Nanobiotix S.A. 23.4%

Value $130M Shares 5,623,816 Share Price $23.12 Est. Cost/Share $6.67 Unrealized @ Report Date +246.6%

RAPP Rapport Therapeutics, Inc. 9.8%

Value $54.14M Shares 1,784,517 Share Price $30.34 Est. Cost/Share $23.15 Unrealized @ Report Date +31.0%

MGTX MeiraGTx Holdings plc 9.5%

Value $52.8M Shares 6,641,064 Share Price $7.95 Est. Cost/Share $9.84 Unrealized @ Report Date -19.2%

CVRX CVRx, Inc. 5.1%

Value $28.58M Shares 4,024,861 Share Price $7.10 Est. Cost/Share $19.85 Unrealized @ Report Date -64.2%

CTNM Contineum Therapeutics Inc. 4.1%

Value $22.62M Shares 1,979,173 Share Price $11.43 Est. Cost/Share $16.10 Unrealized @ Report Date -29.0%

LEGN Legend Biotech Corporation 3.2%

Value $17.71M Shares 814,586 Share Price $21.74 Est. Cost/Share $41.61 Unrealized @ Report Date -47.8%

XNCR Xencor, Inc. 2.1%

Value $11.45M Shares 748,062 Share Price $15.31 Est. Cost/Share $37.91 Unrealized @ Report Date -59.6%

PRCT Procept BioRobotics Corporation 2.0%

Value $11.26M Shares 357,939 Share Price $31.46 Est. Cost/Share $38.38 Unrealized @ Report Date -18.0%

FATE Fate Therapeutics, Inc. 0.6%

Value $3.32M Shares 3,379,064 Share Price $0.98 Est. Cost/Share $78.44 Unrealized @ Report Date -98.8%

NMRA Neumora Therapeutics, Inc. 0.6%

Value $3.311M Shares 1,849,445 Share Price $1.79 Est. Cost/Share $12.57 Unrealized @ Report Date -85.8%

— Rallybio Corporation 0.4%

Value $2.495M Shares 3,636,363 Share Price $0.69 Est. Cost/Share $1.34 Unrealized @ Report Date —

LYEL Lyell Immunopharma, Inc. 0.3%

Value $1.689M Shares 54,887 Share Price $30.78 Est. Cost/Share $11.42 Unrealized @ Report Date +169.5%

VOR Vor Biopharma, Inc. 0.1%

Value $703K Shares 53,732 Share Price $13.08 Est. Cost/Share $18.62 Unrealized @ Report Date -29.8%

NNOX Nano-X Imaging Ltd. 0.1%

Value $445K Shares 158,852 Share Price $2.80 Est. Cost/Share $15.61 Unrealized @ Report Date -82.1%

LAB Standard BioTools, Inc. 0.1%

Value $399K Shares 311,967 Share Price $1.28 Est. Cost/Share $2.41 Unrealized @ Report Date -47.0%

ACET Adicet Bio, Inc. 0.0%

Value $192K Shares 22,779 Share Price $8.42 Est. Cost/Share $11.05 Unrealized @ Report Date -23.8%

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
PTGX	Protagonist Therapeutics Inc.	2,449,183	$214M	38.5%	$87.34	$42.63	+104.9%	COM	74366E102
NBTX	Nanobiotix S.A.	5,623,816	$130M	23.4%	$23.12	$6.67	+246.6%	SPONSORED ADS	63009J107
RAPP	Rapport Therapeutics, Inc.	1,784,517	$54.14M	9.8%	$30.34	$23.15	+31.0%	COM	75383L102
MGTX	MeiraGTx Holdings plc	6,641,064	$52.8M	9.5%	$7.95	$9.84	-19.2%	COM	G59665102
CVRX	CVRx, Inc.	4,024,861	$28.58M	5.1%	$7.10	$19.85	-64.2%	COM	126638105
CTNM	Contineum Therapeutics Inc.	1,979,173	$22.62M	4.1%	$11.43	$16.10	-29.0%	CL A	21217B100
LEGN	Legend Biotech Corporation	814,586	$17.71M	3.2%	$21.74	$41.61	-47.8%	SPONSORED ADS	52490G102
XNCR	Xencor, Inc.	748,062	$11.45M	2.1%	$15.31	$37.91	-59.6%	COM	98401F105
PRCT	Procept BioRobotics Corporation	357,939	$11.26M	2.0%	$31.46	$38.38	-18.0%	COM	74276L105
FATE	Fate Therapeutics, Inc.	3,379,064	$3.32M	0.6%	$0.98	$78.44	-98.8%	COM	31189P102
NMRA	Neumora Therapeutics, Inc.	1,849,445	$3.311M	0.6%	$1.79	$12.57	-85.8%	COM	640979100
—	Rallybio Corporation	3,636,363	$2.495M	0.4%	$0.69	$1.34	—	COM	75120L100
LYEL	Lyell Immunopharma, Inc.	54,887	$1.689M	0.3%	$30.78	$11.42	+169.5%	COM NEW	55083R203
VOR	Vor Biopharma, Inc.	53,732	$703K	0.1%	$13.08	$18.62	-29.8%	COM NEW	929033207
NNOX	Nano-X Imaging Ltd.	158,852	$445K	0.1%	$2.80	$15.61	-82.1%	ORD SHS	M70700105
LAB	Standard BioTools, Inc.	311,967	$399K	0.1%	$1.28	$2.41	-47.0%	COM	34385P108
ACET	Adicet Bio, Inc.	22,779	$192K	0.0%	$8.42	$11.05	-23.8%	COM NEW	007002207